JHOM-1Homo sapiens (Human)Cancer cell line

Also known as: JHOM1

🤖 AI SummaryBased on 7 publications

Quick Overview

Human ovarian cancer cell line for research on molecular mechanisms and drug sensitivity.

Detailed Summary

JHOM-1 is a human ovarian cancer cell line derived from a high-grade serous carcinoma. It is widely used in studies focusing on genomic profiling, drug sensitivity, and molecular mechanisms of cancer progression. Research has shown that JHOM-1 exhibits specific genetic alterations, including mutations in TP53 and other key oncogenes, making it a valuable model for investigating targeted therapies. The cell line is also utilized in comparative studies to evaluate the effectiveness of various anticancer drugs and to understand the relationship between genetic profiles and treatment responses.

Research Applications

Genomic profilingDrug sensitivity testingMolecular mechanism studiesComparative drug efficacy analysis

Key Characteristics

TP53 mutationHigh-grade serous carcinoma originUsed in drug response studies
Generated on 6/21/2025

Basic Information

Database IDCVCL_4644
SpeciesHomo sapiens (Human)
Tissue SourceOvary[UBERON:UBERON_0000992]

Donor Information

Age88
Age CategoryAdult
SexFemale

Disease Information

DiseaseMucinous adenocarcinoma of ovary
LineageOvary/Fallopian Tube
SubtypeMucinous Ovarian Cancer
OncoTree CodeMOV

DepMap Information

Source TypeRIKEN
Source IDACH-000237_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Arg213Ter (c.637C>T)Unspecified-Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
12
D13S317
8,12
D16S539
10,11
D5S818
10
D7S820
10.3,12
TH01
7,9
TPOX
8,11
vWA
14,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Integrated genomic, epigenomic, and expression analyses of ovarian cancer cell lines.

Velculescu V.E., Scharpf R.B.

Cell Rep. 25:2617-2633(2018).

Characterization of human cancer cell lines by reverse-phase protein arrays.

Liang H.

Cancer Cell 31:225-239(2017).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.

Golub T.R., Root D.E., Hahn W.C.

Sci. Data 1:140035-140035(2014).

Evaluating cell lines as tumour models by comparison of genomic profiles.

Domcke S., Sinha R., Levine D.A., Sander C., Schultz N.

Nat. Commun. 4:2126.1-2126.10(2013).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Web Resources